Venous thromboembolism in patients with pancreatic cancer: Implications of circulating tissue factor

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 4, 2011, Pages 295-300

  Delluc, Aurélien ^a,b   Rousseau, Aurélie ^c   Delluc, Céline ^d   Le Moigne, Emmanuelle ^a,b   Le Gal, Grégoire ^a,b   Mottier, Dominique ^a,b   Van Dreden, Patrick ^c   Lacut, Karine ^a,b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^c PAE Parispace 3   (France)

^d Military Teaching Hospital Clermont Tonnerre   (France)

Author keywords

pancreatic cancer; tissue factor; venous thromboembolism

Indexed keywords

D DIMER; FIBRIN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

EID: 79955943870     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834512f4     Document Type: Article

References (24)

1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O?Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonaryembolism: a populationbased case-control study. Arch Intern Med 2000; 160:809-815. (Pubitemid 30165241)
2. Sorensen HT, Mellemkjar L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343:1846-1850. (Pubitemid 32104130)
3. Heit JA. Cancer and venous thromboembolism: scope of the problem. Cancer Control 2005; 12 (Suppl 1):5-10. (Pubitemid 41356174)
4. Mandala M, Reni M, Cascinu S, Barni S, Floriani I, Cereda S, et al. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Ann Oncol 2007; 18:1660-1665. (Pubitemid 47506252)
5. Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol 2004; 5:655-663. (Pubitemid 40267849)
6. Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 2006; 4:529-535.
7. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RC. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346:1004-1005.
8. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, et al. Bloodborne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999; 96:2311-2315. (Pubitemid 29117911)
9. Rak J, Milsom C, Yu J. Tissue factor in cancer. Curr Opin Hematol 2008; 15:522-528.
10. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24:1015-1022.
11. Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 2007; 13:2870-2875. (Pubitemid 46849560)
12. Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 2008; 6:1983-1985.
13. Oger E, Lacut K, Le Gal G, Couturaud F, Guenet D, Abalain J-H, et al. Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost 2006; 4:793-799.
14. ThePIOPEDInvestigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263:2753-2759.
15. Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer 2000; 83:164-170. (Pubitemid 30411712)
16. Nieva J. The clinical significance of circulating tissue factor in prostate cancer. Thromb Haemost 2007; 97:329-330. (Pubitemid 46437790)
17. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBO Study Group. Groupe d?Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83:657-660.
18. Le CoadouG, Bessaguet C, Faycal J, Cauvin J, Robaszkiewicz M,Gouerou H, et al. Incidence de l?adé nocarcinome du pancré as dans le département du Finistè re entre 1990 et 2004 et survie des malades. Gastroenterol Clin Biol 2009; 33:A209.
19. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293:715-722. (Pubitemid 40216041)
20. Blom JW, Osanto S, Rosendaal FR. High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients. Eur J Cancer 2006; 42:410-414. (Pubitemid 43132898)
21. Falanga A, Barbui T, Rickles FR. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies. Semin Thromb Hemost 2008; 34:204-210.
22. Ueda C, Hirohata Y, Kihara Y, Nakamura H, Abe S, Akahane K, et al. Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor. J Gastroenterol 2001; 36:848-850. (Pubitemid 34036909)
23. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007; 5:520-527. (Pubitemid 46680685)
24. Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 2008; 6:1517-1524.